Walleye Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Walleye Capital's AMGN Position: Q1 2026 in Review
Walleye Capital reduced its Amgen (AMGN) stake by 100% in Q1 2026, selling an estimated $3.53M and leaving 25 shares worth $8.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4167.
Walleye Capital first reported a position in AMGN in Q2 2019 and has held it in 14 quarters since. The position peaked at $12.6M in Q1 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Walleye Capital held 25 shares of Amgen worth $8.8K as of Q1 2026.
- Walleye Capital sold 9,889 Amgen shares in Q1 2026, an estimated $3.53M.
- Amgen made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4167 holding.
- Walleye Capital first reported a position in Amgen in Q2 2019 and has held it in 14 quarters since.
- Walleye Capital's Amgen position peaked at $12.6M in Q1 2024.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.